SCHEMBL21333029

SCHEMBL21333029

CON(C)C(=O)c1c(C)nn(Cc2ccccc2)c1C

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.67
LMNA P02545 3/20 0.58
NPC1 O15118 1/20 0.58
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALKBH5 Q6P6C2 1/20 0.53
MAPK1 P28482 2/20 0.51
GAA P10253 2/20 0.51
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.48
TSHR P16473 2/20 0.48
ALOX15 P16050 1/20 0.48
HBB P68871 1/20 0.48
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21333231 0.82 POLB (0.80) POLBLMNANPC1MEN1KMT2A
SCHEMBL8444618 0.81 POLB (1.00) POLBLMNANPC1MEN1KMT2A
SCHEMBL5813326 0.78 SMYD3 (0.51) POLBNPC1MEN1KMT2AGAA
SCHEMBL6070204 0.77 MAPK1 (0.76) POLBLMNANPC1MEN1KMT2A
SCHEMBL21332821 0.77 KMT2A (0.50) POLBLMNANPC1MEN1KMT2A
SCHEMBL5818031 0.77 PTGER1 (0.47) POLBMEN1KMT2AGAA
SCHEMBL21332992 0.77 POLB (0.76) POLBLMNANPC1MEN1KMT2A
SCHEMBL21711349 0.75 POLB (0.72) POLBLMNANPC1MEN1KMT2A
SCHEMBL2163465 0.74 POLB (0.76) POLBLMNANPC1MEN1KMT2A
SCHEMBL5999242 0.72 GAA (0.50) LMNAMEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762377-B1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF UNIV CORNELL (US) 2025-08-20 EP disclosed
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof CORNELL UNIVERSITY (US) 2024-04-23 US disclosed
EP-3762377-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF Cook, Timothy, H. (US) 2021-01-13 EP disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 US disclosed
WO-2019173790-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF HLA TIMOTHY (US) 2019-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF PTGER1, LOXL1, COL1A1 POLB 3175/4885LMNA 907/4885NPC1 1315/4885
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof PTGER1, LOXL1, COL1A1 POLB 3175/4885LMNA 907/4885NPC1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.